JPRN-UMIN000016488已完成未知
Examination of Clinical usefulness of FES-PET for hormone therapy against recurrence after adjuvant hormone therapy of estrogen receptor-positive breast cancer - FES-1
Institusion of Biomedical Resarch and Innovation0 个研究点目标入组 10 人开始时间: 2015年2月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Subject who can not be maintained for 60 minutes on her back Subject who is claustrophobic extremely Subject with poor blood sugar control ( blood glucose kevel is more then 200mg/dl on the examination day)
研究者
相似试验
进行中（未招募）
1 期
The use of FES-PET imaging as a tool to detect a possible reversion of Estrogen Receptor (ER)-a status in patients with metastatic breast cancer HER2 + and ERa neg treated with trastuzumab + pertuzumab + taxane.Metastatic breast cancer HER2 + and ERa neg.MedDRA version: 20.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2018-001552-36-FRINSTITUT CLAUDIUS REGAUD33
已完成
不适用
A pilot study of FES-PET for patients with breast cancerbreast cancerJPRN-UMIN000003124Institute of Biomedical Research and Innovation5
已完成
不适用
Evaluation of clinical usefulness of PET/CT with aminoacid metabolism1.Parathyroid adenoma 2.Multiple myeloma 3.Brain tumor 4.Malignant tumors without FDG avidityJPRN-UMIN000004043Kyoto University Hospital100
已完成
不适用
A pilot study for effective evaluations of FLT-PET in the effect of stereotactic radiotherapy on non-small-cell lung cancerJPRN-UMIN000016489Foundation of Biomedical Research and Innovation2
已完成
2 期
Clinical utility of PET/CT with 18F-FSU-880 for recurrent prostate cancerprostate cancerJPRN-UMIN000034190Kyoto University Hospital74